ISRAELEAK PART 6 - WHY HAVE THEY DECIDED TO STOP THE STUDY?

After they commissioned an external research team to analyze the reports on adverse events, only at the end of 2021, it seems like the Israel Ministry of Health decided to put a stop on the study
because it did not like the findings.
Apparently, one of the findings the Ministry did not like is 155 reports of serious side effects among adults over 18 years of age, which led to hospitalizations or ER visits.
These 155 reports on serious adverse events represent a very high reporting rate, especially given the fact they were collected only from
less than 15 percent of the population and over a year after the vaccination campaign in Israel started. During the study, the researchers identified 173 such reports,
including 19 cases in children up to the age of 17 and 155 reports of serious cases in adults age 18 and older. However the researchers explained that during the study they
were only able to analyze the reporting of hospitalizations and ER referrals in children.

"We collected the data, gathered using the form regarding cases of hospitalization and
emergency room admission That is to say, those who reported indicated whether they were hospitalized or went to ER. We entered it into the Ofek system. We did not enter all the cases of
hospitalization and ER addmissions, only for those who are in this age range, for patients that reported From the age of five.. children up to the age of 17. We actually collected the
relevant medical information around that vaccine. This information was collected, and was concentrated in a dedicated form. And later it was actually sent to committee members who
servied the case before the comitee convened. And at the end of the committee, after the conclusions were received, we consolidated the conclusions of the committee, and sent it to all the members."

As can be seen, these are serious cases of hospitalization due to side effects such as myocarditis and pericarditis in small children On the other hand, as professor Mati Berkowitz,
head of the research team explains: The team has not yet had time to analyze reports on equally serious events, including cardio-vascular events among 155 adults. By the way,
there is another topic of the team meetings.. the E12 team and the children's team, Sasha also summarized them And I think it adds a lot. If we talk about the future,
look there are a hundred and fifty-five Reports of major- i.e. hospitalization or ER admissions of adults, there is no doubt that it is in place to do it just like we did with the children.
MOH prevents the analysis of cases of the most serious AE, which is serious in light of the fact that this is a non-anonymous form so that the cases are identified and can be followed and examined in depth. Moreover, the MOH removed from the formal report it issued in August 2022 any trace of those 155 cases of serious side effects that required hospitalization or ER visits in adults.
The researchers explain to the Ministry of Health during the discussion that they have not yet had time to analyze the reports of additional AE they have identified,
including heart problems that were reported with high frequency among men.

In this meeting, I will discuss the most common affects, O.K.? We have here a database of information that we haven't touched and still haven't analyzed We see here, that there is a significant part
of disorders in the menstrual cycle for females. And here in men we suddenly saw cardiovascular effects that were.. that reached 14 percent of all the phenomena reperted by males and
they did not appear in the female's data. When the findings of the teams' study contradict the Ministry of Health's "safe and effective" narrative, instead of changing its approach,
the Ministry of Health decided to halt the study, delete any evidence of new signals, re-challenge or long-term side effects, including the 155 reports of serious side effects in adults
that required hospitalization or ER visits – and bury the conclusions.

"..the most important thing in my opinion Emil .. is to publish.. to share this with Sharon, Nachman Ash (heads of MOH), they.. I'm looking now also at our common target audience, to continue this venture. It is a shame not to continue it.
A shame!"